Results 261 to 270 of about 104,745 (290)

Genomic Confluence: When Cerebrotendinous Xanthomatosis, Klinefelter Syndrome, and a BRCA2 Variant Intersect. [PDF]

Int J Mol Sci
Pachajoa H, Bonilla S, Nieva-Posso DA.
europepmc   +1 more source

Identification of Actionable Mutations in Metastatic Castration-Resistant Prostate Cancer Through Circulating Tumor DNA: Are We There Yet? [PDF]

Curr Oncol
Tao W, Sabel A, Bonfil RD.
europepmc   +1 more source

Genetic risk and clinical implications of BRCA1 and BRCA2 mutations in Turkish triple-negative breast cancer patients. [PDF]

Discov Oncol
Celik Demirbas B, Kilic Erciyas S, Sukruoglu Erdogan O, Yalniz Kayim Z, Pasin O, Ozgel MC, Tuncer SB.   +6 more
europepmc   +1 more source

EP300 deficiency leads to chronic replication stress mediated by defective replication fork protection. [PDF]

Nat Commun
Barreto-Galvez A, Niljikar M, Gagliardi JE, Guzman CP, Zhang R, Kumar V, Juwarwala A, Pradeep A, Saxena A, Montagna C, Mittal P, Gerhardt J, Xia B, Cao J, Kataoka K, Durbin AD, Qi J, Ye BH, Madireddy A.   +18 more
europepmc   +1 more source

The impact of BRCA mutation and hormone receptor status on the outcomes of fertility preservation in breast cancer patients: a systematic review and meta-analysis. [PDF]

Front Oncol
Ye L, Yang W, Guan H.
europepmc   +1 more source

Alteration of Hyaluronic Acid Metabolism in Tumor Microenvironment Can Modulate DNA Repair Gene Expression: Therapeutic Potential for Triple-Negative Breast Cancer. [PDF]

Int J Mol Sci
Sevic I, Vitale DL, Moran Maidana C, Rosales P, Icardi A, Latina C, Romano L, Brandone A, Giannoni P, Alaniz L.   +9 more
europepmc   +1 more source

Real-world effectiveness of PARP inhibitors after CDK4/6 inhibitor therapy in BRCA-mutated HR-positive/HER2-negative advanced breast cancer. [PDF]

NPJ Breast Cancer
Zattarin E, Marra A, Palazzo A, Griguolo G, Vernieri C, Etessami J, Pontolillo L, Landa G, Daneri A, De Monte M, Cuoghi Costantini R, Tenedini E, Ponzoni O, Razeti MG, Sposetti C, Barbieri E, Manni M, Caggia F, Cortesi L, Curigliano G, Bria E, Dominici M, Guarneri V, Lambertini M, Toss A.   +24 more
europepmc   +1 more source